Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Conting… (NCT04738825) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
United States526 participantsStarted 2021-10-04
Plain-language summary
The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis (PrEP) adherence and support services (CoMPASS) to promote HIV prevention among individuals with opioid use disorder who have injected drugs in their lifetime. In parallel, the investigators will conduct an implementation focused process evaluation to inform real-world implementation of CoMPASS. .
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Receive or willing to receive care at one of the participating study sites
✓. Have a recent negative HIV test with no concern for acute HIV
✓. Report injection drug use in their lifetime
✓. Meet PrEP eligibility criteria by either a) sharing of injection or drug preparation equipment; b) sexual risk behaviors (i.e. condomless sex or STI) in the past 6 months
✓. Meet Diagnostic and Statistical Manual of Mental Disorders - 5th edition (DSM5) criteria for opioid use disorder
✓. Have a phone or use of a household member's phone
✓. Provide written informed consent
✓. Currently employed at one of the participating study sites
Exclusion criteria
✕. Currently prescribed PrEP
✕. Self-report or urine test confirming pregnancy, breastfeeding, or trying to conceive